BCM-PDAC-1 | 4622397 | Pancreatic ductal adenocarcinoma | 79.2 | 3.5 | Tobacco | Borderline | 21.3 | 55 | 58.43 | White | Male | G2 | IIB | Abraxane,Capecitabine,Gemcitabine |
BCM-PDAC-10 | 5695792 | Pancreatic ductal adenocarcinoma | 79 | 0.8 | Tobacco, Pancreatitis | Resectable | 21.0 | 27 | 58.14 | White | Female | G2 | IIB | Folfirinox |
BCM-PDAC-11 | 6046120 | High grade Adenocarcinoma | 421 | 22.7 | Tobacco, Pancreatitis | Resectable | 23.75 | 23 | 59.9 | White | Male | G3 | IIB | Abraxane,Capecitabine,Folfirinox,Folfox,Gemcitabine |
BCM-PDAC-13 | 6125394 | Pancreatic ductal adenocarcinoma | 106 | 0.2 | Diabetes, Tobacco, Pancreatitis | Resectable | 22.5 | 14 | 64.75 | Hispanic or Latino | Male | G3 | IIB | Abraxane,Gemcitabine |
BCM-PDAC-14 | 6142831 | Pancreatic ductal adenocarcinoma | 401.2 | 0.5 | Diabetes | Resectable | 40.05 | 12 | 64.32 | White | Female | G2 | IIB | Gemcitabine |
BCM-PDAC-18 | 6652135 | Pancreatic ductal adenocarcinoma | 1542 | 0.5 | Diabetes | Resectable | 30.75 | 42 | 65.02 | White | Male | G2 | IIB | Abraxane,Capecitabine,Gemcitabine |
BCM-PDAC-19 | 6714659 | Pancreatic ductal adenocarcinoma | 2600 | 2.4 | Tobacco, Diabetes | Resectable | 29.3 | 17 | 71.97 | White | Female | G2 | IIB | Gemcitabine |
BCM-PDAC-2 | 4639492 | Pancreatic ductal adenocarcinoma | 192.2 | 0.6 | Tobacco | Resectable | 22.24 | 15 | 88.58 | White | Male | G2 | IIB | |
BCM-PDAC-25 | 8471998 | Pancreatic ductal adenocarcinoma | 988 | 16.5 | | Resectable | 39.0 | 6 | 66.13 | White | Male | G3 | IIB | folfirinox |
BCM-PDAC-26 | 8635396 | Pancreatic ductal adenocarcinoma | 186 | 0.6 | | Resectable | 22.06 | 15 | 46.68 | Black or African American | Female | G2 | IIB | Gemcitabine,capecitabine |
BCM-PDAC-28 | 8944795 | Adenocarcinoma (pancreatobiliary) | 78 | 6.6 | Tobacco | Resectable | 28.11 | 21 | 59.08 | White | Male | G2.5 | IV | Abraxane with investigational agent (HALO 301),Gemcitabine |
BCM-PDAC-29 | 8988670 | Pancreatic ductal adenocarcinoma | 534 | 0.3 | Diabetes, Tobacco, Pancreatitis | Resectable | 47.01 | 28 | 65.43 | Black or African American | Female | G2 | IIA | Abraxane,Capecitabine,Gemcitabine,capecitabine |
BCM-PDAC-3 | 4642227 | Pancreatic ductal adenocarcinoma | 540 | 0.3 | Tobacco | Metastatic | 23.8 | 0 | 65.45 | White | Female | | IV | |
BCM-PDAC-30 | 8979334 | Pancreatic ductal adenocarcinoma | | Unknown | Diabetes, Tobacco | Resectable | 23.2 | 9 | 76.87 | White | Female | G2 | IIB | Gemcitabine,capecitabine |
BCM-PDAC-31 | 9545904 | Pancreatic ductal adenocarcinoma | | Unknown | Diabetes | Resectable | 26.79 | 9 | 68.68 | White,Hispanic or Latino | Female | G4 | IIB | Abraxane,Gemcitabine |